Evidence map›Paper›PMID 38648869›Full record

ArticleNeuroImage2024

Unraveling the molecular relevance of brain phenotypes: A comparative analysis of null models and test statistics.

Zhipeng Cao, Guilai Zhan, Jinmei Qin, Renata B Cupertino, Jonatan Ottino-Gonzalez, Alistair Murphy, Devarshi Pancholi, Sage Hahn, Dekang Yuan, Peter Callas and 2 more

Abstract readComparative Study
In one paragraph

Article in NeuroImage, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhipeng CaoShanghai Xuhui Mental Health Center, Shanghai 200232, China; Department of Psychiatry, University of Vermont College of Medicine, Burlington VT, 05401, USA. Electronic address: zhipeng30@foxmail.com.
Guilai ZhanShanghai Xuhui Mental Health Center, Shanghai 200232, China.
Jinmei QinShanghai Xuhui Mental Health Center, Shanghai 200232, China.
Renata B CupertinoDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Jonatan Ottino-GonzalezDivision of Endocrinology, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Alistair MurphyDepartment of Psychiatry, University of Vermont College of Medicine, Burlington VT, 05401, USA.
Devarshi PancholiDepartment of Psychiatry, University of Vermont College of Medicine, Burlington VT, 05401, USA.
Sage HahnDepartment of Psychiatry, University of Vermont College of Medicine, Burlington VT, 05401, USA.
Dekang YuanDepartment of Psychiatry, University of Vermont College of Medicine, Burlington VT, 05401, USA.
Peter CallasDepartment of Mathematics and Statistics, University of Vermont College of Engineering and Mathematical Sciences, Burlington VT, 05401, USA.
Scott MackeyDepartment of Psychiatry, University of Vermont College of Medicine, Burlington VT, 05401, USA.
Hugh GaravanDepartment of Psychiatry, University of Vermont College of Medicine, Burlington VT, 05401, USA.

Funding

ENIGMA- Addiction: Pooling of Existing Datasets to Identify Brain and Genetic Correlates of Addiction, Next StepsR01DA047119 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HUGH P. GARAVAN · 2018 to 2026
$5.4M
NIDA NIH HHS R01 DA047119
6 · The paper itself

Abstract

Correlating transcriptional profiles with imaging-derived phenotypes has the potential to reveal possible molecular architectures associated with cognitive functions, brain development and disorders. Competitive null models built by resampling genes and self-contained null models built by spinning brain regions, along with varying test statistics, have been used to determine the significance of transcriptional associations. However, there has been no systematic evaluation of their performance in imaging transcriptomics analyses. Here, we evaluated the performance of eight different test statistics (mean, mean absolute value, mean squared value, max mean, median, Kolmogorov-Smirnov (KS), Weighted KS and the number of significant correlations) in both competitive null models and self-contained null models. Simulated brain maps (n = 1,000) and gene sets (n = 500) were used to calculate the probability of significance (Psig) for each statistical test. Our results suggested that competitive null models may result in false positive results driven by co-expression within gene sets. Furthermore, we demonstrated that the self-contained null models may fail to account for distribution characteristics (e.g., bimodality) of correlations between all available genes and brain phenotypes, leading to false positives. These two confounding factors interacted differently with test statistics, resulting in varying outcomes. Specifically, the sign-sensitive test statistics (i.e., mean, median, KS, Weighted KS) were influenced by co-expression bias in the competitive null models, while median and sign-insensitive test statistics were sensitive to the bimodality bias in the self-contained null models. Additionally, KS-based statistics produced conservative results in the self-contained null models, which increased the risk of false negatives. Comprehensive supplementary analyses with various configurations, including realistic scenarios, supported the results. These findings suggest utilizing sign-insensitive test statistics such as mean absolute value, max mean in the competitive null models and the mean as the test statistic for the self-contained null models. Additionally, adopting the confounder-matched (e.g., coexpression-matched) null models as an alternative to standard null models can be a viable strategy. Overall, the present study offers insights into the selection of statistical tests for imaging transcriptomics studies, highlighting areas for further investigation and refinement in the evaluation of novel and commonly used tests.

Indexed as

BrainPhenotypeGene Expression ProfilingHumansModels, StatisticalTranscriptomeCompetitive null modelsGene set analysisImaging-derived phenotypesImaging-transcriptomicsSelf-contained null models

Identifiers

PMID38648869
PMCPMC11132826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.